Kinney Drugs has partnered with EnlivenHealth to offer FREE Medicare Part D plan comparisons for seniors, according to the ...

Medicare Part B costs will rise in 2026. Here's what to expect, including higher prescription drug prices and payment changes ...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and ...

The Green River Area Development District is offering free help to Medicare beneficiaries during the Part D Open Enrollment ...

Based on a months-long negotiation process between CMS and the manufacturers of these 15 drugs, the final negotiated prices altogether represent savings of 44% on net spending that Medicare would ...

Health insurers are pulling out of the Medicare Advantage market. Discover which areas will gain or lose the most, and what to do if your plan is canceled.

A new round of Medicare drug price negotiations shows the impact of the Inflation Reduction Act while exposing an ongoing political fight over who deserves credit for lowering drug costs. The Trump ...

The government said Tuesday that Novo Nordisk's (NVO) drugs - Ozempic and Rybelsus for Type 2 diabetes - will cost $274 for a month's supply in 2027 for people covered by Medicare. Wegovy, which is ...

The Trump administration’s negotiation with Novo Nordisk A/S that slashes 71% off the list price of its blockbusters Ozempic ...

The Trump administration tapped a Biden-era rule to negotiate lower prices on 15 widely used medications for seniors.

The cost of some drugs for Medicare beneficiaries is decreasing, but it won’t come immediately. Here's when to expect them.

On Tuesday, the Trump administration celebrated drug price cuts it had secured through a Democrat-created program — despite Republicans’ longstanding antipathy of the policy.